Zurcher Kantonalbank (Zurich Cantonalbank) Adicet Bio, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$2.13 - $7.13 $12,371 - $41,411	-5,808 Reduced 99.97%	2 $0
Q1 2023 May 08, 2023	SELL	$5.52 - $9.23 $7,457 - $12,469	-1,351 Reduced 18.87%	5,810 $33,000
Q4 2022 Feb 01, 2023	BUY	$7.72 - $21.27 $42,375 - $116,751	5,489 Added 328.29%	7,161 $64,000
Q1 2022 Apr 21, 2022	BUY	$11.53 - $19.97 $7,898 - $13,679	685 Added 69.4%	1,672 $33,000
Q4 2021 Feb 01, 2022	BUY	$7.37 - $17.49 $7,274 - $17,262	987 New	987 $17,000

Others Institutions Holding ACET

# of Institutions

Shares Held

59.2M

Call Options Held

4.2K

Put Options Held

6.7K

Orbimed Advisors LLC San Diego, CA

11.4M
Shares

$11 Million
0.39% of portfolio
Tang Capital Management LLC San Diego, CA

8.22M
Shares

$7.89 Million
1.01% of portfolio
Ra Capital Management, L.P. Boston, MA

7.54M
Shares

$7.24 Million
0.15% of portfolio
Goldman Sachs Group Inc New York, NY

3.76M
Shares

$3.61 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.21M
Shares

$3.08 Million
0.0% of portfolio

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $38.4M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account